QuidelOrtho (QDEL) Consolidated Net Income (2021 - 2024)
QuidelOrtho (QDEL) posted Consolidated Net Income of -$1.7 billion for Q1 2024, down 222.8% sequentially from -$528.5 million in Q4 2023, and down 3595.9% YoY from $48.8 million in Q2 2023.
QuidelOrtho (QDEL) Consolidated Net Income (2021 - 2024) Analysis & Trends
QuidelOrtho has reported Consolidated Net Income for 4 years, with the latest figure at -$1.7 billion in Q1 2024.
- Quarterly Consolidated Net Income fell 3595.9% year-over-year to -$1.7 billion in Q1 2024, while the trailing twelve-month figure through Dec 2024 was -$1.7 billion (down 212.68% YoY) and the FY2024 annual result came in at -$2.1 billion, down 20216.83% from the prior year.
- Consolidated Net Income declined to -$1.7 billion in Q1 2024 per QDEL's latest filing, from -$528.5 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $479.9 million in Q2 2022 and troughed at -$1.7 billion in Q1 2024.
- A 4-year average of -$123.9 million and a median of $19.2 million in 2022 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2024: Consolidated Net Income advanced 1.05% in 2022, then slumped 3595.9% in 2024.
- Over 4 years, Consolidated Net Income stood at $215.7 million in 2021, then sank by 91.1% to $19.2 million in 2022, then slumped by 2852.6% to -$528.5 million in 2023, then plunged by 222.8% to -$1.7 billion in 2024.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$1.7 billion, -$528.5 million, and -$12.7 million for Q1 2024, Q4 2023, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | QuidelOrtho | 1.01 Bn | 885.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.71 Bn |
| Dec 31, 2023 | -528.50 Mn |
| Oct 1, 2023 | -12.70 Mn |
| Jul 2, 2023 | -53.20 Mn |
| Apr 2, 2023 | 48.80 Mn |
| Jan 1, 2023 | 135.80 Mn |
| Oct 2, 2022 | 19.20 Mn |
| Jul 3, 2022 | 19.30 Mn |
| Apr 3, 2022 | 479.90 Mn |
| Oct 3, 2021 | 215.70 Mn |
| Jul 4, 2021 | 19.10 Mn |